India
In-Vitro diagnostic market is anticipated to witness impressive growth during
the forecast period. This can be ascribed due to increase in IVF technologies,
IVF technology has improved significantly in recent years, with the development
of new techniques such as intracytoplasmic sperm injection (ICSI),
preimplantation genetic testing (PGT), and frozen embryo transfer (FET). These
advances have improved the success rates of IVF. Also, chronic and infectious
diseases are on the rise, with an aging population, changing lifestyle
patterns, and rising prevalence of risk factors such as obesity and smoking.
This has led to a growing demand for diagnostic tests to detect and monitor
these diseases, driving the growth of the India in-vitro diagnostics market.
Increase in disposable income and healthcare spending, due to India's growing
middle class and increasing disposable income have led to greater healthcare
spending, including fertility treatments such as IVF. This has led to the
establishment of more IVF centers and increased accessibility of these
treatments. In-vitro diagnostics tests can be used to diagnose, monitor, and
manage diseases and medical conditions, and are an important tool for
healthcare professionals in making informed decisions about patient care. The
Indian government has implemented several policies and programs to support
assisted reproductive technologies, including the National Health Mission and
the National Guidelines for Accreditation, Supervision, and Regulation of
assisted reproductive technology clinics in India. These policies have improved
the availability and affordability of IVF treatments in the country. There is a
growing focus on quality control and regulatory compliance in the India
in-vitro diagnostics market, as healthcare providers seek to ensure the
accuracy and reliability of diagnostic test results.
Improvement
in IVF Technologies
In
vitro fertilization (IVF) is a medical procedure used to help couples conceive
a child when other fertility treatments have not been successful. IVF involves
fertilizing an egg with sperm outside the body, in a laboratory dish, and then
implanting the fertilized egg into the uterus. In recent years, there have been
several advances in IVF technologies in India. Pre-implantation genetic testing
(PGT) is a technique used to test the embryos for genetic disorders before they
are implanted into the uterus. This technology helps in selecting healthy
embryos for implantation, reducing the risk of genetic diseases in the
offspring. Cryopreservation of eggs and embryos is a process of freezing and
storing eggs and embryos for future use. This technology has improved the
success rates of IVF by allowing couples to store and use embryos in future IVF
cycles. Time-lapse imaging is a technique that involves taking continuous
images of the developing embryos to track their growth and development. This
technology helps embryologists to select the best embryos for implantation.
Intra-Cytoplasmic Sperm Injection (ICSI) is a technique used to inject a single
sperm directly into an egg, which can improve fertilization rates in cases of
male infertility. Natural cycle IVF is a technique that involves retrieving a
single egg during a woman's natural menstrual cycle, without the use of
fertility drugs. This technique has lower costs and fewer side effects than
conventional IVF but is only suitable for certain women with good fertility
potential. These advances in IVF technologies have led to improved success
rates and reduced risks and costs associated with IVF in India. Additionally,
the use of these technologies has made IVF accessible to a wider range of
couples, including those with complex fertility issues or genetic disorders.
This factor is one of the major reasons for the growth of the India in-vitro
diagnostics market.
Increase
in Disposable Income and Healthcare Infrastructure
In-vitro
diagnostics tests and procedures can be expensive, and many people may not be
able to afford them. However, as disposable income increases, more people will
be able to pay for these tests and procedures, which, in turn, will drive the
demand for in-vitro diagnostic products and services. In addition, an increase
in disposable income may lead to a greater emphasis on preventive healthcare,
as people may be more willing to invest in maintaining their health and
detecting diseases early. This can lead to a greater demand for screening and
diagnostic tests. The in-vitro diagnostics market relies heavily on healthcare
infrastructure, including hospitals, clinics, diagnostic laboratories, and
imaging centers, to provide testing services and to access patients for
diagnosis and treatment. A well-developed healthcare infrastructure is
essential for the effective delivery of in-vitro diagnostics services, as it
provides the necessary facilities, equipment, and skilled personnel to carry
out diagnostic tests and procedures. For instance, advanced diagnostic
equipment such as molecular testing machines, mass spectrometers, and imaging
technologies are essential for carrying out accurate and reliable diagnostic
tests. A robust healthcare infrastructure can also help to increase access to
in-vitro diagnostics services in remote and rural areas of the country, where
healthcare facilities may be limited. Healthcare infrastructure can also
contribute to the development of the India in-vitro diagnostics market by providing
a conducive environment for research and development activities. For instance,
academic institutions and research centers can collaborate with the industry to
develop new and innovative in-vitro diagnostic products and technologies. This
factor will accelerate the growth of the India in-vitro diagnostics market
during the forecast period.
Increasing
Cases of Cancer, Diabetes, And Cardiovascular Diseases
The
prevalence of these diseases is on the rise in India due to factors such as
changing lifestyles, increasing urbanization, and aging population. According
to the World Health Organization (WHO), cancer, diabetes, and cardiovascular
diseases are among the leading causes of death in India. In-vitro diagnostic
tests play a critical role in the diagnosis and monitoring of these diseases.
For instance, in-vitro diagnostic tests can be used to detect cancer at an
early stage, allowing for timely intervention and treatment. Similarly,
in-vitro diagnostic tests can be used to monitor blood glucose levels in
diabetic patients, enabling healthcare providers to adjust treatment plans as
necessary. In the case of cardiovascular diseases, in-vitro diagnostic tests can
help to diagnose and monitor conditions such as high blood pressure and
cholesterol levels, which are risk factors for heart disease. The growing
incidence of these diseases is expected to increase the demand for in-vitro
diagnostic tests in India. The Indian government has also taken several
initiatives to address the growing burden of non-communicable diseases,
including cancer, diabetes, and cardiovascular diseases. For instance, the
National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular
Diseases, and Stroke (NPCDCS) was launched in 2010 to provide universal
screening, diagnosis, and treatment for these diseases. This factor will drive
the growth of the India in-vitro diagnostic market during the forecast period.
Download Free Sample Report
Recent
Development
In
2021, Siemens Healthineers India collaborated with Bengaluru-based startup
Dozee to develop an AI-powered solution for remote patient monitoring. The
solution aims to improve patient outcomes and reduce the burden on healthcare
providers.
In
2021, Thermo Fisher Scientific announced the acquisition of Mesa Biotech, a
US-based company that specializes in molecular diagnostic tests. This
acquisition is expected to strengthen Thermo Fisher Scientific's position in
the global in-vitro diagnostics market, including India.
In
2020, Roche Diagnostics India announced a collaboration with Cipla to expand
the access to COVID-19 testing in India. Under this collaboration, Roche
Diagnostics India supplied the cobas SARS-CoV-2 Test to Cipla, which is
distributed to government and private testing centers across India.
In
2020, TransAsia Bio-Medicals announced a collaboration with Japanese IVD
company Eisai Co. Ltd. to develop and manufacture diagnostic tests for the
Indian market. This collaboration is expected to strengthen TransAsia’s
position in the India in-vitro diagnostics market during the forecast period.
Market
Segmentation
The
India in-vitro diagnostics market can be segmented into by product type, by
technology, by application, by end user, and by region. By product type, the
market can be segmented into instruments, reagents, and software &
services. By technology, the market can be segmented into immunoassay,
hematology, clinical chemistry, molecular diagnostics, microbiology, and
others. By application, the market can be segmented into infectious diseases,
diabetes, oncology, cardiology, nephrology, and others. By end user, the market
can be segmented into hospitals & clinics, diagnostic centers &
laboratories, and others. By region, the market can be segmented into North
India, South India, East India, and West India.
Market
Players
J
Mitra & Co Pvt Ltd., Advatech Healthcare Pvt Ltd., Tulip Diagnostics PVT.
Ltd., Transasia Bio-Medicals Ltd., BD India Pvt Ltd., Siemens Healthcare Pvt.
Ltd., and Bio-Rad Laboratories India Pvt. Ltd. are some of the market players
in the India in-vitro diagnostics market.
|
Attribute
|
Details
|
|
Base Year
|
2023
|
|
Historic Data
|
2019 – 2022
|
|
Estimated Year
|
2024
|
|
Forecast Period
|
2025 – 2029
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2018-2023
and 2024-2029
|
|
Report Coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments Covered
|
Product Type
Technology
Application
End User
|
|
Regional scope
|
North India, South India, East India, West India
|
|
Key companies profiled
|
J Mitra & Co Pvt Ltd., Advatech
Healthcare Pvt Ltd., Tulip Diagnostics PVT. Ltd., Transasia Bio-Medicals
Ltd., BD India Pvt Ltd., Siemens Healthcare Pvt. Ltd., Bio-Rad Laboratories
India Pvt. Ltd.
|
|
Customization scope
|
10% free report customization with purchase. Addition or alteration to
country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to
meet your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable version
of the report in PPT/Word format on special request)
|
Report
Scope:
In
this report, the India in-vitro diagnostics market has been segmented into the
following categories, in addition to the industry trends which have also been
detailed below:
- India In-vitro
Diagnostics Market, By Product Type:
o Instruments
o Reagents
o Software &
Services
- India In-vitro
Diagnostics Market, By Technology:
o Immunoassay
o Hematology
o Clinical
Chemistry
o Molecular
Diagnostics
o Microbiology
o Others
- India In-vitro
Diagnostics Market, By Application:
o Infectious
Diseases
o Diabetes
o Oncology
o Cardiology
o Nephrology
o Others
- India In-vitro
Diagnostics Market, By End User:
o Hospitals &
Clinics
o Diagnostic
Centers & Laboratories
o Others
- IndiaIn-vitro
Diagnostics Market, By Region:
o North India
o South India
o East India
o West India
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies present in the India in-vitro diagnostics
market.
Available
Customizations:
With
the given market data, TechSci Research offers customizations according to a
company’s specific needs. The following customization options are available for
the report:
Company
Information
- Detailed
analysis and profiling of additional market players (up to five).
India
in-vitro diagnostics market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]